- About this Journal ·
- Abstracting and Indexing ·
- Advance Access ·
- Aims and Scope ·
- Annual Issues ·
- Article Processing Charges ·
- Articles in Press ·
- Author Guidelines ·
- Bibliographic Information ·
- Citations to this Journal ·
- Contact Information ·
- Editorial Board ·
- Editorial Workflow ·
- Free eTOC Alerts ·
- Publication Ethics ·
- Reviewers Acknowledgment ·
- Submit a Manuscript ·
- Subscription Information ·
- Table of Contents
BioMed Research International
Volume 2013 (2013), Article ID 730721, 9 pages
Preexisting High Expression of Matrix Metalloproteinase-2 in Tunica Media of Saphenous Vein Conduits Is Associated with Unfavorable Long-Term Outcomes after Coronary Artery Bypass Grafting
1Departments of Cardiac Surgery and Transplantology, Poznan University of Medical Sciences, ul. Dluga 1/2, 61-848 Poznan, Poland
2Histology and Embryology, Poznan University of Medical Sciences, ul. Dluga 1/2, 61-848 Poznan, Poland
3Pediatric Cardiology and Nephrology, Poznan University of Medical Sciences, ul. Dluga 1/2, 61-848 Poznan, Poland
4Anesthesiology and Intensive Therapy, Poznan University of Medical Sciences, ul. Dluga 1/2, 61-848 Poznan, Poland
Received 8 June 2013; Accepted 19 August 2013
Academic Editor: Rei Shibata
Copyright © 2013 Bartlomiej Perek et al. This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.
- R. D. Lopes, G. E. Hafley, K. B. Allen et al., “Endoscopic versus open vein-graft harvesting in coronary-artery bypass surgery,” The New England Journal of Medicine, vol. 361, no. 3, pp. 235–244, 2009.
- P. Klinkert, P. N. Post, P. J. Breslau, and J. H. van Bockel, “Saphenous vein versus PTFE for above-knee femoropopliteal bypass. A review of the literature,” European Journal of Vascular and Endovascular Surgery, vol. 27, no. 4, pp. 357–362, 2004.
- T. Pfeiffer, L. Reiher, K. Grabitz et al., “Reconstruction for renal artery aneurysm: operative techniques and long-term results,” Journal of Vascular Surgery, vol. 37, no. 2, pp. 293–300, 2003.
- J. A. Friedman and D. G. Piepgras, “Current neurosurgical indications for saphenous vein graft bypass,” Neurosurgical Focus, vol. 14, no. 3, pp. e1–e3, 2003.
- J. G. Motwani and E. J. Topol, “Aortocoronary saphenous vein graft disease: pathogenesis, predisposition, and prevention,” Circulation, vol. 97, no. 9, pp. 916–931, 1998.
- A. Muto, L. Model, K. Ziegler, S. D. D. Eghbalieh, and A. Dardik, “Mechanisms of vein graft adaptation to the arterial circulation—insights into the neointimal algorithm and management strategies,” Circulation Journal, vol. 74, no. 8, pp. 1501–1512, 2010.
- R. S. Schwartz, “Pathophysiology of restenosis: interaction of thrombosis, hyperplasia, and/or remodeling,” American Journal of Cardiology, vol. 81, no. 7, pp. 14E–17E, 1998.
- M. J. Domanski, C. B. Borkowf, L. Campeau et al., “Prognostic factors for atherosclerosis progression in saphenous vein grafts: The Postcoronary Artery Bypass Graft (Post-CABG) Trial,” Journal of the American College of Cardiology, vol. 36, no. 6, pp. 1877–1883, 2000.
- S.-A. Hassantash, B. Bikdeli, S. Kalantarian, M. Sadeghian, and H. Afhar, “Pathophysiology of aortocoronary saphenous vein bypass graft disease,” Asian Cardiovascular and Thoracic Annals, vol. 16, no. 4, pp. 331–336, 2008.
- A. K. Mitra, D. M. Gangahar, and D. K. Agrawal, “Cellular, molecular and immunological mechanisms in the pathophysiology of vein graft intimal hyperplasia,” Immunology & Cell Biology, vol. 84, no. 2, pp. 115–124, 2006.
- J. L. Johnson, G. J. J. M. van Eys, G. D. Angelini, and S. J. George, “Injury induces dedifferentiation of smooth muscle cells and increased matrix-degrading metalloproteinase activity in human saphenous vein,” Arteriosclerosis, Thrombosis, and Vascular Biology, vol. 21, no. 7, pp. 1146–1151, 2001.
- N. A. Turner, K. T. Hall, S. G. Ball, and K. E. Porter, “Selective gene silencing of either MMP-2 or MMP-9 inhibits invasion of human saphenous vein smooth muscle cells,” Atherosclerosis, vol. 193, no. 1, pp. 36–43, 2007.
- M. Crowther, S. Goodall, J. L. Jones, P. R. F. Bell, and M. M. Thompson, “Increased matrix metalloproteinase 2 expression in vascular smooth muscle cells cultured from abdominal aortic aneurysms,” Journal of Vascular Surgery, vol. 32, no. 3, pp. 575–583, 2000.
- J. D. Raffetto and R. A. Khalil, “Matrix metalloproteinases and their inhibitors in vascular remodeling and vascular disease,” Biochemical Pharmacology, vol. 75, no. 2, pp. 346–359, 2008.
- J. L. Johnson, A. H. Baker, K. Oka et al., “Suppression of atherosclerotic plaque progression and instability by tissue inhibitor of metalloproteinase-2: involvement of macrophage migration and apoptosis,” Circulation, vol. 113, no. 20, pp. 2435–2444, 2006.
- G. Murphy, “Tissue inhibitors of metalloproteinases,” Genome Biology, vol. 12, no. 11, article 233, 2011.
- B. Aravind, B. Saunders, T. Navin et al., “Inhibitory effect of TIMP influences the morphology of varicose veins,” European Journal of Vascular and Endovascular Surgery, vol. 40, no. 6, pp. 754–765, 2010.
- S. Goldman, K. Zadina, T. Moritz et al., “Long-term patency of saphenous vein and left internal mammary artery grafts after coronary artery bypass surgery: results from a Department of Veterans Affairs Cooperative Study,” Journal of the American College of Cardiology, vol. 44, no. 11, pp. 2149–2156, 2004.
- A. J. Epstein, D. Polsky, F. Yang, L. Yang, and P. W. Groeneveld, “Coronary revascularization trends in the united states, 2001–2008,” The Journal of the American Medical Association, vol. 305, no. 17, pp. 1769–1776, 2011.
- G. M. FitzGibbon, H. P. Kafka, A. J. Leach, W. J. Keon, G. D. Hooper, and J. R. Burton, “Coronary bypass graft fate and patient outcome: angiographic follow-up of 5,065 grafts related to survival and reoperation in 1,388 patients during 25 years,” Journal of the American College of Cardiology, vol. 28, no. 3, pp. 616–626, 1996.
- M. H. Gault, L. L. Longerich, J. D. Harnett, and C. Wesolowski, “Predicting glomerular function from adjusted serum creatinine,” Nephron, vol. 62, no. 3, pp. 249–256, 1992.
- W. Remmele and H. E. Stegner, “Recommendation for uniform definition of an immunoreactive score (IRS) for immunohistochemical estrogen receptor detection (ER-ICA) in breast cancer tissue,” Pathologe, vol. 8, no. 3, pp. 138–140, 1987.
- B. Perek, A. Malinska, M. Nowicki, et al., “Histological evaluation of age-related variations in saphenous vein grafts used for coronary artery bypass grafting,” Archieves of Medical Sciences, vol. 8, no. 6, pp. 1041–1047, 2012.
- J. D. Flaherty and C. J. Davidson, “Diabetes and coronary revascularization,” The Journal of the American Medical Association, vol. 293, no. 12, pp. 1501–1508, 2005.
- M. Endo, Y. Tomizawa, and H. Nishida, “Bilateral versus unilateral internal mammary revascularization in patients with diabetes,” Circulation, vol. 108, no. 11, pp. 1343–1349, 2003.
- S. J. George, A. B. Zaltsman, and A. C. Newby, “Surgical preparative injury and neointima formation increase MMP-9 expression and MMP-2 activation in human saphenous vein,” Cardiovascular Research, vol. 33, no. 2, pp. 447–459, 1997.
- S. Yongxin, D. Wenjun, W. Qiang, et al., “Heavy smoking before coronary surgical procedures affects the native matrix metalloproteinase-2 and matrix metalloproteinase-9 gene expression in saphenous vein conduits,” The Annals of Thoracic Surgery, vol. 95, no. 1, pp. 55–62, 2013.
- K. M. Southgate, D. Mehta, M. B. Izzat, A. C. Newby, and G. D. Angelini, “Increased secretion of basement membrane-degrading metalloproteinases in pig saphenous vein into carotid artery interposition grafts,” Arteriosclerosis, Thrombosis, and Vascular Biology, vol. 19, no. 7, pp. 1640–1649, 1999.
- Z. S. Galis and J. J. Khatri, “Matrix metalloproteinases in vascular remodeling and atherogenesis: the good, the bad, and the ugly,” Circulation Research, vol. 90, no. 3, pp. 251–262, 2002.
- R. Pyo, J. K. Lee, J. M. Shipley et al., “Targeted gene disruption of matrix metalloproteinase-9 (gelatinase B) suppresses development of experimental abdominal aortic aneurysms,” Journal of Clinical Investigation, vol. 105, no. 11, pp. 1641–1649, 2000.
- M. H. Tayebjee, I. Karalis, S. K. Nadar, D. G. Beevers, R. J. MacFadyen, and G. Y. H. Lip, “Circulating matrix metalloproteinase-9 and tissue inhibitors of metalloproteinases-1 and -2 levels in gestational hypertension,” American Journal of Hypertension, vol. 18, no. 3, pp. 325–329, 2005.
- A. W. Chung, A. D. Booth, C. Rose, C. R. Thompson, A. Levin, and C. Van Breemen, “Increased matrix metalloproteinase 2 activity in the human internal mammary artery is associated with ageing, hypertension, diabetes and kidney dysfunction,” Journal of Vascular Research, vol. 45, no. 4, pp. 357–362, 2008.
- J. P. Spiers, E. J. Kelso, W. F. Siah et al., “Alterations in vascular matrix metalloproteinase due to ageing and chronic hypertension: effects of endothelin receptor blockade,” Journal of Hypertension, vol. 23, no. 9, pp. 1717–1724, 2005.